baber/WOPTO huggingface dataset:
Patent NZ-239501-A (NZ)
Title: Treatment of unbleached wood pulp by adding a xylanase to it before the last washing, apparatus therefor
Inventor: PEDERSEN LARS SAABY
IPC: D21C5/00
Filed: 1991-08-22
Abstract: A process for treatment of lignocellulosic pulp comprising a multistage washing of the unbleached kraft brown stock and a xylanase treatment. The xylanase treatment is carried out in a holding tank introduced upstream the first washing unit or downstream one or more of the other washing units except for the last washing unit.
Patent NZ-244175-A (NZ)
Title: A dentrifice composition comprising a stable peroxide compound
Inventor: NATHOO SALIM A
IPC: A61K8/24
Filed: 1992-09-01
Abstract: Abrasive dentifrice compositions containing an oxygen liberating whitening compound which is stable with respect to oxygen level and exhibits heightened and rapid whitening of teeth and stain removal which comprises a combination of a dicalcium phosphate compound and a metal ion free peroxide compound.
Patent NZ-244726-A (NZ)
Title: Substituted 1-azabicyclo[2.2.1]heptan-3-oxime derivatives and pharmaceutical compositons thereof
Inventor: LAUFFER DAVID JEFFREY
IPC: C07D405/12
Filed: 1992-10-14
Abstract: Pharmaceutically useful nitrogen containing cyclic oxime and amine substituted compounds are disclosed which are azabicyclo[2.2.2]oximes, azabicyclo[2.2.2]-amines, azabicyclo[3.2.1]oximes and amine containing heterocyclic oximes wherein the heterocyclic ring contains from 3 to 7 carbon atoms.
Patent NZ-248012-A (NZ)
Title: Connection device for lan ring bypasses out-of-service station
Inventor: GUEZOU JEAN
IPC: H04L69/40
Filed: 1993-06-29
Abstract: The connection device provides a link between an operating station, and one or several data rings. The device includes switching modules (M1a,M1b) associated with signal generating modules (PMD) for regenerating a signal. The modules are connected in order to be able to bypass a station (Si) when it is out of service, compensating for the attenuation of amplitude and phase shift introduced by the line section situated above it.
Patent NZ-250718-A (NZ)
Title: Preparation of maleamic acid
Inventor: BRUN DANIEL
IPC: C07C233/65
Filed: 1994-01-20
Abstract: The subject of the present invention is a process for the preparation of maleamic acid from maleic anhydride and ammonia, characterised in that the maleic anhydride, in a molten form, and gaseous ammonia are brought together under operating conditions such that the contact surface area between the two compounds is optimised.
Patent NZ-268449-A (NZ)
Title: Oil-in-water emulsion with castor oil as the lipid phase and egg yolk phospholipids as an emulsifier: for administration of steroids
Inventor: JONASSON HALLGRIMUR
IPC: A61K31/57
Filed: 1994-07-01
Abstract: The present invention relates to novel oil-in-water emulsions especially suitable for parenteral administration of bioactive steroids which otherwise are difficult to solubilize in conventional solvents. The emulsions will comprise a lipid phase containing castor oil.
Patent NZ-277095-A (NZ)
Title: Peptide that exhibits potent surface activity, lung surfactant containing such and its use in treating respiratory distress syndrome
Inventor: TAKEI TSUNETOMO
IPC: C07K14/785
Filed: 1994-12-07
Abstract: A synthetic peptide containing the following sequence: Xaa-Pro-Val-Xbb-Xcc-Lys-Arg-W, (wherein Xaa is absent or represents Cys or Ser; Xbb represents His or Asn; Xcc represents Leu or Ile; and W represents a hydrophobic peptide portion); an intermediate for producing the peptide; a process for producing the peptide; a lung surfactant comprising the peptide and a lipid mixture; and a remedy for respiratory distress syndrome containing the surfactant as the active ingredient. The peptide is easy to isolate and purify and suitable for mass production. As it is highly soluble in methanol and the like, it can readily be blended with a lipid mixture and is suited for the preparation of a lung surfactant. As the lung surfactant has a good suspensibility and a potent surface activity, it is useful as a remedy for respiratory distress syndrome.
Patent NZ-277804-A (NZ)
Title: Method of inhibiting plugging of pipelines/conduits by the addition of a gas hydrates
Inventor: KLOMP ULFERT CORNELIS
IPC: C09K8/52
Filed: 1994-12-20
Abstract: A method is provided for inhibiting the formation of hydrates in streams containing low-boiling hydrocarbons and water. The method includes adding to the stream a component of the formula: <IMAGE> wherein R1, R2, and R3 are independently chosen from the group consisting of normal and branched alkyls having at least 4 carbon atoms, and X is N-R4, wherein R4 is selected from the group consisting of hydrogen and organic substituents and Y- is an anion. The amount added is an amount that is effective to inhibit formation of hydrates in the mixture at conduit temperatures and pressures. The preferred R4 is an alkyl or alkenyl having from eight to twenty carbons, and the preferred R1, R2, and R3 are alkyls having four to six carbon atoms.
Patent NZ-330422-A (NZ)
Title: Web of thermoplastic material comprising spaced apart recloseable fasteners with interlocking profiles removable sealing means
Inventor: OLSEN LAWRENCE JOSEPH
IPC: B65D53/08
Filed: 1998-05-13
Abstract: A reclosable plastic bag comprises a first sheet of plastic film material, a second sheet of plastic film material, joined to the first sheet at its entire perimeter and a reclosable fastener 1 of a kind having or including two self-interlocking profile strips 3, 4.  Each profile strip 3, 4 is connected to an internal surface of one of the first or second sheets of plastic film in a position to overly an opening or region 7 capable of creating an opening in one of the first or second sheets of plastic film.  A removable sealing means 10 overlies the entire opening or region 7 and is capable of creating an opening in one of the first or second sheets of plastic film on the exterior surface thereof.
Patent NZ-334561-A (NZ)
Title: Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents
Inventor: SANKARAM MANTRIPRAGADA B SANKA
IPC: B01J13/12
Filed: 1995-09-13
Abstract: process for producing multivesicular liposomes comprising the steps of:  a)	forming a water in oil emulsion from two immiscible components, a lipid component comprising at least one solvent, at least one amphipathic lipid and a triglyceride, and a frst aqueous component comprising at least one biologically active substance; b)	dispersing the waterr in oil emulsion into a second aqueous component to form solvent spherules; c)	removing the solvent from the solvent spherules to form the multivesiclar liposomes wherein the osmolarity of the first  aqueous component is chosen to modulate the rate of release from multivesicular liposomes into a physiologically relevant aqueous environment. Also claimed is the multivesicular liposome produced by the above process.
Patent NZ-335084-A (NZ)
Title: Use of Rhodococcus and Nocardia bacterium species in degrading zearalenone in plants
Inventor: ROOD TRACY A
IPC: A23L5/20
Filed: 1997-11-12
Abstract: Rhodococcus globerulus, Rhodococcus erythropolis and Nocardia globerula have the ability to degrade or detoxify zearalenone, or derivatives or analogs of zearalenone.  These microbes can be used to detoxify corn and maize, pre- or post-harvest. The zearalenone-degradation gene has been isolated and can be introduced into suitable microorganisms.
Patent NZ-335302-A (NZ)
Title: Low residue aqueous hard surface cleaning and disinfecting compositions
Inventor: HARRISON KENNETH A
IPC: C11D3/30
Filed: 1997-10-15
Abstract: These aqueous based cleaning compositions simultaneously feature disinfecting, low residue deposit and good cleaning characteristics. The compositions include: 1)	one or more quaternary amine compounds as disinfecting agents,  and 2)	an organic solvent system which includes: a)	a glycol mono-n-butyl ether or a binary system including a glycol ether with a linear primary alcohol, b)	either one or more betaines, or one or more amine oxides as a surfactant constituent, and c)	an alkanolamine.
Patent NZ-336149-A (NZ)
Title: Particle-mediated transformation of differentiated pinus embryos
Inventor: CONNETT-PORCEDDU MARIE BERNICE
IPC: C12N15/87
Filed: 1999-06-04
Abstract: This method of genetically engineering conifers of the genus Pinus, comprises: a)	placing conifer embryonic target tissue containing pre stage 3 embryos on a target surface: b)	bombarding the target tissue with particles carrying at least one gene of interest and a selection gene; c)	inducing the bombarded tissue; d)	culturing the bombarded tissue, to select transformed embryonic tissue; e)	inducing the development of transformed somatic embryos; and f)	germinating and converting the transformed somatic embryos to produce clonal transgenic plants.
Patent NZ-501111-A (NZ)
Title: Medical pump tubing having a first layer of ethylene copolymerized with alkyl olefins or alkyl and alkene esters of carboxylic acid
Inventor: WOO LECON
IPC: A61M5/142
Filed: 1999-05-24
Abstract: A medical tubing for use with a pump for administering measured amounts of a beneficial fluid over time to a patient comprises a sidewall of the tubing having a first layer of either ethylene homopolymers or ethylene copolymers wherein the tubing has been exposed to a sterilization dosage of radiation of from 15 to 45 kGys.  The ethylene copolymers are ethylene co polymerized with a monomer being alkyl olefins, alkyl esters of a carboxylic acid and alkene esters of a carboxylic acid.  The sidewall has a melt flow index of less than 5.0 g/10 minutes.
Patent NZ-501332-A (NZ)
Title: Salts of optically active spiro[benzo[c]thiophene-1(3H),4'-piperidin]-2-oxide as antagonists against both P receptors and neurokinin A receptors
Inventor: YAMAGUCHI TAKESHI
IPC: A61K31/5377
Filed: 1998-05-27
Abstract: The hydrochloride or fumarate of 1-{2-[(2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2yl]ethyl}spiro[benzo(c)thiophene-1(3H), 4'-piperidin]-(2S)-oxide.  The compounds act to inhibit NK1 or NK2 receptors and are useful in treating tachykinin-mediated diseases, asthma, bronchitis, rhinitis, urinary incontinence and ulcerative colitis.
Patent NZ-506004-A (NZ)
Title: Online document assembler
Inventor: WORTHINGTON STEVE
IPC: G06F17/21
Filed: 2000-07-27
Abstract: A document assembly system where packets of text relating to particular documents are stored in a library. The online user is asked questions relating to the type of document required and blocks of stored text are selected according to the user's decisions. Software assembles the selected text and populates the assembled document with user data. The software delivers the assembled document to the user. A database stores the user data.
Patent NZ-507791-A (NZ)
Title: Triterpene compositions from Acacia victoriae and methods for use thereof
Inventor: ARNTZEN CHARLES J
IPC: A61K41/00
Filed: 1999-05-19
Abstract: A mixture comprises one or more isolated triterpene glycosides characterized by the following properties: isolatable from the tissues of Acacia victoriae, containing at least one triterpene glycoside having a molecular weight of from 1800 to 2600 and having the ability to induce cytotoxicity and apoptosis in a Jurkat cell, activate caspase 3 in a Jurkat cell, cause cleavage of PARP in a Jurkat cell, inhibit the activity of PI-3-kinase in a Jurkat cell, induce the release of cytochrome c from the mitochondria in a Jurkat cell or inhibit the initiation and promotion of mammalian epithelial cells to a premalignant or malignant state. The mixture can be formed into neutracuetical compositions. Process for preparing a mixture of isolated triterpene glycosides from tissue cultures of Acacia victoriae plant using a solvent are described. Also described are compositions comprising a triterpene moiety attached to a monoterpene moiety having the molecular formula of formula I wherein: R1 and R2 are hydrogen, C1-C5 alkyl or an oligosaccharide R3 is hydrogen, hydroxyl, C1-C5 alkyl, C1-C5 alkylene, C1-C5 alkyl carbonyl, a sugar or a monoterpene group; and the formula further comprising R4, wherein R4 is hydrogen, hydroxyl, C1-C5 alkyl, C1-C5 alkylene, C1-C5 alkyl carbonyl, a sugar, C1-C5alkyl ester or a monoterpene, and may be attached to the triterpene moiety or the monoterpene moiety. The composition can be used in the preparation of pharmaceutical compositions for inhibiting the initiation and promotion of a mammalian epithelial cell to a premalignant or malignant state, inducing apoptosis in a malignant cell, for preventing abnormal proliferation of an epithelia cell, for treating inflammation or for regulating angiogenesis.
Patent NZ-510644-A (NZ)
Title: Dosing container for administration of products used in health care, in which the treatment volume can be determined precisely
Inventor: BAYER MICHAEL
IPC: B65D23/12
Filed: 1999-09-10
Abstract: Described is a dosing container (1) which matches the volume of administration products to the body weight of the object (animal or human) requiring the product.  The dosing container is comprised of a transparent material and has a constant filling cross section (6).  A dosage slide (10) provided with a scale (11) can be adjusted in a vertical position of the dosing container (1) to the actual filling level (15) while using the scale value (14) which corresponds to the actual body weight of the object.  The end of the treatment is indicated when the zero value (12) corresponds to the new filling level (16).
Patent NZ-511181-A (NZ)
Title: Improvements to rotor tips
Inventor: ROBSON ANGUS
IPC: B02C13/18
Filed: 2001-05-06
Abstract: A method of assembling a rotor for use in a rock crusher and characterized by the step of positioning a resilient material between a rotor tip holder and the rotor.
Patent NZ-513648-A (NZ)
Title: Aromatic sulfone hydroxamic acid metalloprotease inhibitor
Inventor: HOCKERMAN SUSAN L
IPC: C07D211/08
Filed: 2000-02-22
Abstract: A compound or a salt thereof has the formula (VI) wherein g, m, n and p are independently 0 to 2 and the sum of m + n + p = 1 to 4; one of X, Y and Z is C(O), NR6, O, S, S(O), S(O)2 or NS(O)2R7, and the remaining two of X, Y and Z are CR8R9 or CR10R11 or X and Z or Z and Y together constitute a moiety selected from NR6C(O), NR6S(O), NR6S(O)2, NR6S, NR6O, SS, NR6NR6 or OC(O), with the remaining one of X, Y and Z being CR8R9 or n is zero and X, Y and Z together constitute a moiety of formula (II); R20 is NR26R27; R3 is an optionally substituted aryl or heteroaryl radical or R3 is G-A-R-E-Y2; G is an aryl or heteroaryl group; A is -O-, -S-, -NR17-, -CO-N(R17)-, -N(R17)-CO-, -O-CO-, - CO-O-, -O-CO-O-, -HC=CH-, -NH-CO-NH-, -CºC, -O-CO-NH-, -NH- CO-O-, -N=N-, -NH-NH-, -CS-N(R18)-, -N (R18)-CS- or a bond; R is alkyl, alkoxyalkyl, aryl, heteroaryl, cycloalkyl, heterocyclo, aralkyl, heteroaralkyl, heterocycloalkyl, cycloalkylalkyl, cycloalkoxyalkyl, heterocycloalkoxyalkyl, aryloxyalkyl, heteroaryloxyalkyl, arylthioalkyl, heteroarylthioalkyl, cycloalkylthioalkyl or a heterocycloalkylthioalkyl wherein the heterocyclo is saturated and the aryl or heteroaryl or cycloalkyl or heterocyclo is optionally substituted and R is other than alkyl or alkoxyalkyl when A is -O- or -S-; E is -CO(R19)-, (R19)CO-, -CONH-, -HNCO-, -CO-, -SO2-R19-, - R19-SO2-, -SO2, -NH-SO2- -SO2-NH- or a bond; Y2 is H, alkyl, alkoxy, haloalkyl, aryl, aralkyl, cycloalkyl, heteroaryl, hydroxy, aryloxy, aralkoxy, heteroaryloxy, heteroaralkyl, perfluoroalkoxy, perfluoroalkylthio, trifluoromethylalkyl, alkenyl, saturated heterocyclo, cycloalkyl, trifluoromethyl, alkoxycarbonyl, or aminoalkyl wherein the aryl or heteroaryl or heterocyclo is optionally substituted and R6 to R13, R6', R12', R17 to R19, R26 and R27 are defined in the specification. An intermediate compound has the formula VII wherein D is a nucleophilically displaceable leaving group and m, n, g, R20, X, Y and Z are as defined above.
Patent NZ-513777-A (NZ)
Title: Method crystallising N-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide
Inventor: LAU HANS-HERMANN
IPC: C07D261/18
Filed: 2000-02-12
Abstract: A process for obtaining the compound of the formula I from a solution containing water, at least one organic solvent selected from the group comprising water-miscible solvents, such as (C1-C4)-alcohols, e.g. methanol, ethanol, propanol, isopropanol, butanol or isobutanol, but also ketones, such as acetone or methyl ethyl ketone, or mixtures of the solvents or mixtures of the solvents with water-immiscible solvents, such as ethyl acetate, toluene or dichloromethane, the compound of the formula I and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamidem which comprises: (a)  Quantitatively dtermining the amount of N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamidem in the solution; (b)  Adding the amount of a base selected from the roup comprising inorganic bases, such as sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate, ammonium bicarbonate, potassium hydrogen phosphate, sodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, potassium dihydrogen phosphate or tripotassium phosphate, which corresponds to form 50 mol% to 150 mol% of the amount of N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamidem determined in (a). (c)  Crystallising the compound of the formula I; nd (d)  Separating the resulting crystals of the cmpound of the formula 1 from the solution.
Patent NZ-513991-A (NZ)
Title: Iodine preparation composition
Inventor: PARSONS DAVE
IPC: A61P17/02
Filed: 2000-03-13
Abstract: An iodine preparation composition for use on wounds, comprising an iodide source, an oxidant, and a buffer capable of maintaining the pH of the composition between 4.5-6, wherein said iodide and said oxidant are held separate from each other until the point of use. Said composition will deliver iodine at a rate high enough to provide effective antisepsis but low enough to avoid problems associated with high levels, achieved by manipulating the pH so as to control the kinetics of the generation of iodine.
Patent NZ-516280-A (NZ)
Title: Frequency lock loop circuit using phase discriminator, low pass filter,differentiator and integrator
Inventor: LEWIS KEITH
IPC: H03D13/00
Filed: 2001-12-19
Abstract: A frequency lock loop (1) includes: a phase discriminator (11) for generating a phase error signal indicative of phase error between a feedback signal (18) and reference signal (17), a filter (12) for extracting from the error signal, a interim signal relating to frequency difference between the feedback and reference signals, a differentiator (13) for differentiating the interim signal to obtain a frequency error signal, an integrator (15) for generating a control signal for a signal generator from the frequency error signal, and a signal generator (16) for producing an output signal (19) with a frequency adjusted by the control signal, wherein the feedback signal is or is derived from the output signal (19).
Patent NZ-520634-A (NZ)
Title: Integral side wall and tap hole cover for an eccentric bottom tap (EBT) furnace
Inventor: ARTHUR MARK THOMAS
IPC: F27B3/16
Filed: 2000-11-07
Abstract: Spray cooled side wall and tap hole cover for an eccentric bottom tap (EBT) electric furnace which is unitary, i.e. one-piece, and has an inter-connected coolant supply and inter-connected spent coolant drain.
Patent NZ-520706-A (NZ)
Title: Drug containing particles with one layer of enteric polymer and one of enteric polymer mixed with a water insoluable polymer
Inventor: PERCEL PHILLIP J
IPC: A61K9/26
Filed: 2001-02-08
Abstract: A pharmaceutical dosage form such as a capsule capable of delivering therapeutic agents into the body in a time-controlled or position-controlled pulsatile release fashion, is composed of a multitude of multicoated particulates (beads, pellets, granules, etc.) made of one or more populations of beads. Each of these beads except an immediate release bead has at least two coated membrane barriers. One of the membrane barriers is composed of an enteric polymer while the second membrane barrier is composed of a mixture of water insoluble polymer and an enteric polymer. The composition and the thickness of the polymeric membrane barriers determine the lag time and duration of drug release from each of the bead populations. Optionally, an organic acid containing intermediate membrane may be applied for further modifying the lag time and/or the duration of drug release. The pulsatile delivery may comprise one or more pulses to provide a plasma concentration-time profile for a therapeutic agent, predicted based on both its pharmaco-kinetic and pharmaco-dynamic considerations and in vitro/in vivo correlations.
Patent NZ-522004-A (NZ)
Title: Child-resistant closure and container package
Inventor: BROZELL BRIAN J
IPC: B65D55/08
Filed: 2002-10-16
Abstract: A child-resistant closure and container package that includes a container having a finish with at least one external thread and pockets in said external thread, and a closure having a base wall, a peripheral skirt with at least one internal thread, lugs on said internal thread for receipt in said pockets, and a spring element for engagement with said finish to bias said closure away from said finish and urge said lugs into said pockets, one of said internal thread and said external thread having a circumferentially facing axially extending stop at an end of said thread, and the other of said internal thread and said external thread having an abutment face at an end of said other thread for abutment with said stop to prevent over-tightening of said closure on said finish and over- compression of said spring element.
Patent NZ-532763-A (NZ)
Title: Method of administering a thymosin alpha 1 peptide
Inventor: RUDOLPH ALFRED R
IPC: A61P37/04
Filed: 2002-11-01
Abstract: Disclosed is the use of a Thymosin alpha 1 (TA1) peptide for the preparation of a pharmaceutical form for a patient in need of immune stimulation in which the form is adapted for continuous administration at a substantially constant flow rate.
Patent NZ-534200-A (NZ)
Title: System, method and apparatus for pattern recognition with application to symbol recognition and regeneration for a caligraphic display
Inventor: ANDERSON BRUCE
IPC: G06F3/147
Filed: 2000-12-21
Abstract: A display system apparatus comprises: a display device comprising at least a two-dimensional array of display pixels; at least one two-dimensional image memory that stores pixel values that reflect a specific display image; refresh circuitry that refreshes the display device from the pixel values stored in the at least one two-dimensional image memory; a signal input set comprised of at least one input signal; a pattern recognition apparatus that recognizes the symbols of a first symbol set from the signal input set and further comprising an output that identifies recognized symbols of the first symbol set; a rendering circuit that independently renders any of the symbols of a second symbol set into the at least one two-dimensional image memory; a plurality of memory tables residing within at least one physical memory device; addressing circuitry that derives a sequence of address values from the signal input set and applies the sequence of address values to address inputs of a corresponding sequence of memory tables from the plurality of memory tables to perform a sequence of memory table-look-up operations for producing a result that comprises the output that identifies recognized symbols of the first symbol set, and interfacing circuitry that, in response to the output from the pattern recognition apparatus, commands the rendering of symbols from the second symbol set by the rendering circuitry. The variation over time of input values for the signal input set reflects symbols for display on the display device. The signal input set comprises an analog X deflection input, an analog Y deflection input, and at least one video input signal. A recognised symbol of the first symbol set results in the rendering of an associated symbol from the second symbol set. (62) Divided out of 520196